肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2009年
12期
833-836
,共4页
黄丙俭%刘莲花%王剑%申源峰%刘庆涛
黃丙儉%劉蓮花%王劍%申源峰%劉慶濤
황병검%류연화%왕검%신원봉%류경도
鼻咽肿瘤%放射疗法%计算机辅助%放射肿瘤学
鼻嚥腫瘤%放射療法%計算機輔助%放射腫瘤學
비인종류%방사요법%계산궤보조%방사종류학
Nasopharyngeal neoplasms%Radiotherapy%computer-assisted%Radiation oncology
目的 对比观察两种不同模拟定位方式对鼻咽癌常规放射治疗的疗效及不良反应的影响.方法 147例首程治疗的鼻咽癌病例随机分成研究组(CT模拟定位组)74例和对照组(X线片模拟定位组)73例,研究组用三维治疗计划系统(TPS)勾画靶区和危机器官.然后用TPS的射野方向观(BEV)功能进行计划设计及后续的计划调整;对照组用X线模拟定位片完成.两组计划设计及后续的计划调整模式完全相同,放射治疗在同一台加速器上进行.结果 随访5~59个月,两组鼻咽原发灶、颈部淋巴结转移灶近期疗效差异均无统计学意义(P>0.05);研究组、对照组3年局部复发率分别为5.4%(4/74)及16.4%(12/73),差异有统计学意义(P<0.05);两组远处转移率分别为12.2%(9/74)及19.2%(14/73),差异无统计学意义(P>0.05);1年与3年累积生存率研究组分别为98.5%、77.4%.对照组分别为92.9%、64.7%,经Log-Rank检验.两组差异有统计学意义(P<0.05);对照组Ⅱ、Ⅲ度口咽黏膜放疗反应较研究组明显增多(P<0.05);对照组发生2例放射性脑病,1例视神经损伤;但两组均无严重的皮肤、软组织纤维化及放射性后组颅神经损伤发生.结论 应用CT模拟定位能提高鼻咽癌常规放射治疗疗效,减少复发和放射不良反应.
目的 對比觀察兩種不同模擬定位方式對鼻嚥癌常規放射治療的療效及不良反應的影響.方法 147例首程治療的鼻嚥癌病例隨機分成研究組(CT模擬定位組)74例和對照組(X線片模擬定位組)73例,研究組用三維治療計劃繫統(TPS)勾畫靶區和危機器官.然後用TPS的射野方嚮觀(BEV)功能進行計劃設計及後續的計劃調整;對照組用X線模擬定位片完成.兩組計劃設計及後續的計劃調整模式完全相同,放射治療在同一檯加速器上進行.結果 隨訪5~59箇月,兩組鼻嚥原髮竈、頸部淋巴結轉移竈近期療效差異均無統計學意義(P>0.05);研究組、對照組3年跼部複髮率分彆為5.4%(4/74)及16.4%(12/73),差異有統計學意義(P<0.05);兩組遠處轉移率分彆為12.2%(9/74)及19.2%(14/73),差異無統計學意義(P>0.05);1年與3年纍積生存率研究組分彆為98.5%、77.4%.對照組分彆為92.9%、64.7%,經Log-Rank檢驗.兩組差異有統計學意義(P<0.05);對照組Ⅱ、Ⅲ度口嚥黏膜放療反應較研究組明顯增多(P<0.05);對照組髮生2例放射性腦病,1例視神經損傷;但兩組均無嚴重的皮膚、軟組織纖維化及放射性後組顱神經損傷髮生.結論 應用CT模擬定位能提高鼻嚥癌常規放射治療療效,減少複髮和放射不良反應.
목적 대비관찰량충불동모의정위방식대비인암상규방사치료적료효급불량반응적영향.방법 147례수정치료적비인암병례수궤분성연구조(CT모의정위조)74례화대조조(X선편모의정위조)73례,연구조용삼유치료계화계통(TPS)구화파구화위궤기관.연후용TPS적사야방향관(BEV)공능진행계화설계급후속적계화조정;대조조용X선모의정위편완성.량조계화설계급후속적계화조정모식완전상동,방사치료재동일태가속기상진행.결과 수방5~59개월,량조비인원발조、경부림파결전이조근기료효차이균무통계학의의(P>0.05);연구조、대조조3년국부복발솔분별위5.4%(4/74)급16.4%(12/73),차이유통계학의의(P<0.05);량조원처전이솔분별위12.2%(9/74)급19.2%(14/73),차이무통계학의의(P>0.05);1년여3년루적생존솔연구조분별위98.5%、77.4%.대조조분별위92.9%、64.7%,경Log-Rank검험.량조차이유통계학의의(P<0.05);대조조Ⅱ、Ⅲ도구인점막방료반응교연구조명현증다(P<0.05);대조조발생2례방사성뇌병,1례시신경손상;단량조균무엄중적피부、연조직섬유화급방사성후조로신경손상발생.결론 응용CT모의정위능제고비인암상규방사치료료효,감소복발화방사불량반응.
Objective To compare and observe the effect and side effect of two different kinds of simulation mode for nasopharyngeal carcinoma conventional radiotherapy. Methods 147 cases were randomly divided into the study group (74 cases, CT simulation) and the control group (73 cases, X-ray radiography simulation). In the study group three-dimensional treatment planning system (IPS) was used to draw target volume and organ at risk, and then beam eye view (BEV) function was utilized to design treatment plan and subsequent plan modulation. In the control group X-ray simulation radiography was used. Two groups of plan design and subsequent plan modulation mode were exactly the same, and the radiotherapy were performed on the same accelerator. Results For these two groups, there were 5-59 months follow-up. The recent therapeutic effect of nasopharyngeal carcinoma primary site and cervical lymph node metastasis was regular,and no statistical significance (P >0.05). For the study group 3-year local recurrence rate was 5.4 % (4/74) while the control group was 16.4 %(12/73), and there was obvious statistical significance between two groups. About one year and three year accumulated survival rate, the study group was 98.5 %, 77.4 %, and for the control group was 92.9 %, 64.7 %. Two groups survival curves were examined by Log-rank test: the survival curves showed statistical significance between two groups(P <0.05). In control group, stage II and III radiotheray reaction of oralis mucosa was significantly increased compared with that of the study group (P < 0.05). There were two cases radioactivity cerebral palsy and one case optic nerve damage in the control group, but no serious dermatosis, soft tissue fibrosis and radioactivity posterior cranial nerve damage. Conclusion The CT simulation which is applied to nasopharyngeal carcinoma conventional radiotheraphy could improve therapeutic effect and reduce cancer recurrence and radiation side effect.